Rakovina Therapeutics (TSXV:RKV) EPS (Basic) : C$-0.06 (TTM As of Mar. 2025)

View and export this data going back to 2021. Start your Free Trial

What is Rakovina Therapeutics EPS (Basic)?

Rakovina Therapeutics's basic earnings per share (Basic EPS) for the three months ended in Mar. 2025 was C$-0.02. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2025 was C$-0.06.

Rakovina Therapeutics's EPS (Diluted) for the three months ended in Mar. 2025 was C$-0.02. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2025 was C$-0.06.

Rakovina Therapeutics's EPS without NRI for the three months ended in Mar. 2025 was C$-0.02. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2025 was -0.06.

During the past 3 years, the average EPS without NRI Growth Rate was -5.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 4 years, Rakovina Therapeutics's highest 3-Year average EPS without NRI Growth Rate was -5.20% per year. The lowest was -5.20% per year. And the median was -5.20% per year.

Rakovina Therapeutics EPS (Basic) Historical Data

The historical data trend for Rakovina Therapeutics's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Rakovina Therapeutics EPS (Basic) Chart

Rakovina Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

EPS (Basic)

-0.10

-0.04

-0.05

Rakovina Therapeutics Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
EPS (Basic)	Get a 7-Day Free Trial												-0.01	-0.01	-0.01	-0.02	-0.02

Rakovina Therapeutics EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Rakovina Therapeutics's Basic EPS for the fiscal year that ended in Dec. 2024 is calculated as

Basic EPS (A: Dec. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-4.073	-	0)	/	82.549
	=	-0.05

Rakovina Therapeutics's Basic EPS for the quarter that ended in Mar. 2025 is calculated as

Basic EPS (Q: Mar. 2025 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(-2.18	-	0)	/	140.773
	=	-0.02

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.06

Rakovina Therapeutics (TSXV:RKV) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Rakovina Therapeutics EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Rakovina Therapeutics's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Rakovina Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rakovina Therapeutics Inc (TSXV:RKV) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

RKVTF:USA

Address

105 1008 Beach Avenue, Vancouver, BC, CAN, V6E 1T7

Website

https://www.rakovinatherapeutics.com

Rakovina Therapeutics Inc is a biopharmaceutical research company focused on the development of cancer treatments. Its work is based on technologies for targeting the DNA-damage response powered by Artificial Intelligence (AI) using proprietary, generative AI platforms. By using AI, it can review and optimize drug candidates at a much greater pace than ever before. The company has established a pipeline of distinctive DNA-damage response inhibitors with the goal of advancing one or more drug candidates into human clinical trials in collaboration with pharmaceutical partners.

Executives

Jeffrey Bacha	Senior Officer
Alfredo De Lucrezia	Director, Senior Officer
Michael Liggett	Director
Mads Daugaard	Senior Officer
David Hyman	Senior Officer
John Michael Langlands	Senior Officer

Rakovina Therapeutics Headlines

No Headlines